Rabies Virus (RV) Glycoprotein Expression Levels Are Not Critical for Pathogenicity of RV

Por Wirblich, Christoph, Schnell, Matthias J.
Publicado em 2011

SARS-CoV-2 vaccines — the biggest medical research project of the 21st century

Por Kurup, Drishya, Schnell, Matthias J
Publicado no Curr Opin Virol (2021)

Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae

Por Faul, Elizabeth J., Lyles, Douglas S., Schnell, Matthias J.
Publicado em 2009

Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics

Por Pfaller, Christian K., Cattaneo, Roberto, Schnell, Matthias J.
Publicado no Virology (2015)

The Glycoprotein and the Matrix Protein of Rabies Virus Affect Pathogenicity by Regulating Viral Replication and Facilitating Cell-to-Cell Spread

Por Pulmanausahakul, Rojjanaporn, Li, Jianwei, Schnell, Matthias J., Dietzschold, Bernhard
Publicado em 2008

A NOVEL COMPOSITE IMMUNOTOXIN THAT SUPPRESSES RABIES VIRUS PRODUCTION BY THE INFECTED CELLS

Por Mareeva, Tatiana, Wanjalla, Celestine, Schnell, Matthias J., Sykulev, Yuri
Publicado em 2009

Keeping it in check: chronic viral infection and antiviral immunity in the brain

Por Miller, Katelyn D., Schnell, Matthias J., Rall, Glenn F.
Publicado no Nat Rev Neurosci (2016)

Status of Antiviral Therapeutics against Rabies Virus and Related Emerging Lyssaviruses

Por DuPont, Venice, Plemper, Richard K, Schnell, Matthias J
Publicado no Curr Opin Virol (2019)

Everything you always wanted to know about Rabies Virus (but were afraid to ask)

Por Davis, Benjamin M., Rall, Glenn F., Schnell, Matthias J.
Publicado no Annu Rev Virol (2015)

The spread and evolution of rabies virus: conquering new frontiers

Por Fisher, Christine R., Streicker, Daniel G., Schnell, Matthias J.
Publicado no Nat Rev Microbiol (2018)

Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2

Por Kurup, Drishya, Wirblich, Christoph, Ramage, Holly, Schnell, Matthias J.
Publicado no NPJ Vaccines (2020)

A ROLE FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE REGULATION OF CD8(+) T CELL RESPONSES TO RABIES VIRUS

Por Wanjalla, Celestine N., Goldstein, Elizabeth F., Wirblich, Christoph, Schnell, Matthias J.
Publicado em 2012

Rhabdovirus-Based Vaccine Platforms against Henipaviruses

Por Kurup, Drishya, Wirblich, Christoph, Feldmann, Heinz, Marzi, Andrea, Schnell, Matthias J.
Publicado no J Virol (2014)

Rabies Virus as a Research Tool and Viral Vaccine Vector

Por Gomme, Emily A., Wanjalla, Celestine N., Wirblich, Christoph, Schnell, Matthias J.
Publicado no Adv Virus Res (2011)

Immunogenicity of Cytopathic and Noncytopathic Viral Vectors

Por Plesa, Gabriela, McKenna, Philip M., Schnell, Matthias J., Eisenlohr, Laurence C.
Publicado em 2006

The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription

Por Tan, Gene S., Preuss, Mirjam A. R., Williams, John C., Schnell, Matthias J.
Publicado em 2007

Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in presence of vector-specific immunity

Por Wanjalla, Celestine N., Faul, Elizabeth J., Gomme, Emily A., Schnell, Matthias J.
Publicado em 2010

Both Viral Transcription and Replication Are Reduced when the Rabies Virus Nucleoprotein Is Not Phosphorylated

Por Wu, Xianfu, Gong, Xiaoming, Foley, Heather D., Schnell, Matthias J., Fu, Zhen F.
Publicado em 2002

Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway

Por Li, Jianwei, McGettigan, James P., Faber, Milosz, Schnell, Matthias J., Dietzschold, Bernhard
Publicado em 2007

Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity

Por Faul, Elizabeth J., Wanjalla, Celestine N., McGettigan, James P., Schnell, Matthias J.
Publicado em 2008